News

Asahi Chemical Industry today announced the commencement of operations at its new assembly facility for Planova-brand filters in the city of Nobeoka, Miyazaki Prefecture, Japan.

"The viral safety of biologicals remains of paramount importance to manufacturers and health authorities worldwide," said Yasuichiro Yano, General Manager, Planova™ Division, Asahi Chemical Industry Co., Ltd. "Filtration with Planova™ filters offers manufacturers yet another means to ensure the viral safety of their biotherapeutic products."

Demand worldwide for Planova™ filters continues to grow as both industry and regulators recognize the merits of incorporating a filtration step to remove viruses during the manufacture of biotechnological and human plasma-derived products.

Asahi Chemical Industry commercially launched Planova™ filters in 1989 as the world's first filter specifically designed to remove viral material from biotherapeutic products. Planova™ filters have won high acclaim from biopharmaceutical and plasma derivative manufacturers worldwide for their ability to remove high levels of viral material such as the human immunodeficiency virus (HIV), hepatitis C virus (HCV) and parvovirus B19, while maintaining high product protein throughput.